Picture of Gensight Biologics SA logo

SIGHT — Gensight Biologics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Gensight Biologics' GS030 Optogenetic Treatment Shows Promising Results In Nature Report

May 25 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * ANNOUNCES NATURE MEDICINE CASE REPORT SHOWING VISUAL
RECOVERY
AFTER GS030 OPTOGENETIC TREATMENT

Source text for Eikon:  ID:nBw1RkhMqa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))

Recent news on Gensight Biologics SA

See all news